FDA Inspection 994781 — Grifols Therapeutics LLC
The FDA completed an inspection of Grifols Therapeutics LLC on Oct 21, 2016 in Clayton, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- Oct 21, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Clayton, NC (United States)